tiprankstipranks
Eagle Pharmaceuticals Inc (EGRX)
NASDAQ:EGRX

Eagle Pharmaceuticals (EGRX) Stock Forecast & Price Target

185 Followers
See the Price Targets and Ratings of:

EGRX Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Eagle
Pharmaceuticals
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EGRX Stock 12 Month Forecast

There Are No Analyst Ratings for EGRX In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

EGRX Financial Forecast

EGRX Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

EGRX Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler
$17.00
Sell
273.63%
Upside
Downgraded
08/09/23
Eagle Pharmaceuticals downgraded to Underweight from Neutral at Piper SandlerEagle Pharmaceuticals downgraded to Underweight from Neutral at Piper Sandler

Best Analysts Covering Eagle Pharmaceuticals

Which Analyst Should I Follow If I Want to Buy EGRX and Sell After:
1 Month
David AmsellemPiper Sandler
Success Rate
7/14 ratings generated profit
50%
Average Return
+3.44%
downgraded a sell rating 9 months ago
Copying David Amsellem's trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +3.44% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
David AmsellemPiper Sandler
Success Rate
7/14 ratings generated profit
50%
Average Return
-0.78%
downgraded a sell rating 9 months ago
Copying David Amsellem's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -0.78% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
David AmsellemPiper Sandler
Success Rate
5/14 ratings generated profit
36%
Average Return
+9.60%
downgraded a sell rating 9 months ago
Copying David Amsellem's trades and holding each position for 1 Year would result in 35.71% of your transactions generating a profit, with an average return of +9.60% per trade.
2 Years
David AmsellemPiper Sandler
Success Rate
4/14 ratings generated profit
29%
Average Return
-3.99%
downgraded a sell rating 9 months ago
Copying David Amsellem's trades and holding each position for 2 Years would result in 28.57% of your transactions generating a profit, with an average return of -3.99% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EGRX Analyst Recommendation Trends

Rating
Nov 22
Jan 23
Mar 23
May 23
Aug 23
Strong Buy
0
0
0
0
0
Buy
1
1
1
1
0
Hold
2
2
3
3
3
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
3
3
4
4
4
In the current month, EGRX has received 0 Buy Ratings, 3 Hold Ratings, and 1 Sell Ratings. EGRX average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

EGRX Stock Forecast FAQ

What is EGRX’s average 12-month price target, according to analysts?
Currently, no data Available
What is EGRX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for EGRX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is EGRX a Buy, Sell or Hold?
      Currently, no data Available
      What is Eagle Pharmaceuticals Inc’s price target?
      Currently, no data Available
      What do analysts say about Eagle Pharmaceuticals Inc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of EGRX?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis